Inhaled Antibiotic and Biologic Formulations Targeting <i>Pseudomonas aeruginosa</i>
Lower respiratory tract infections caused by <i>Pseudomonas aeruginosa</i> are a global concern. Patients with chronic lung diseases such as cystic fibrosis and non-cystic fibrosis bronchiectasis often do not receive adequate antibiotic delivery through conventional routes. <i>P. aeruginosa</i> empl...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2026-01-01
|
| Серии: | Pharmaceutics |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1999-4923/18/2/162 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
